These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 40404)

  • 1. Cell substrates. Their use in the production of vaccines and other biologicals.
    Adv Exp Med Biol; 1979; 118():1-220. PubMed ID: 40404
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell substrates. Their use in the production of vaccines and other biologicals. Past achievements - future expectations.
    Meyer HM
    Adv Exp Med Biol; 1979; 118():1-5. PubMed ID: 495259
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell substrates. Their use in the production of vaccines and other biologicals. Benefit-risk assessment.
    Dull HB
    Adv Exp Med Biol; 1979; 118():187-93. PubMed ID: 495265
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of cell substrates for the production of biologicals: Revision of WHO recommendations. Report of the WHO Study Group on Cell Substrates for the Production of Biologicals, 22-23 April 2009, Bethesda, USA.
    Knezevic I; Stacey G; Petricciani J; Sheets R;
    Biologicals; 2010 Jan; 38(1):162-9. PubMed ID: 19818645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell substrates for biologicals other than vaccines. Introductory remarks.
    Vilcek J
    Adv Exp Med Biol; 1979; 118():115-27. PubMed ID: 495261
    [No Abstract]   [Full Text] [Related]  

  • 6. WHO Expert Committee On Biological Standardization.
    World Health Organ Tech Rep Ser; 1998; 878():i-vi, 1-101. PubMed ID: 9731464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals: application to influenza vaccine production.
    Griffiths E
    Dev Biol Stand; 1999; 98():153-7; discussion 167. PubMed ID: 10494968
    [No Abstract]   [Full Text] [Related]  

  • 8. Much ado about Biologicals: Highlights of the Master Class on Biologicals, Prague, 2018.
    Diamant Z; Vijverberg SJ; Agache I; Bjermer L; Chaker A; Gevaert P; Hellings PW; Nair P; O'Mahony L; Panzner P; Pohunek P; Vašáková M
    Allergy; 2019 Apr; 74(4):837-840. PubMed ID: 30506938
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings of the Joint ESACT -- IABS meeting on the use of heteroploid and other cell substrates for the production of biologicals. Heidelberg (F.R. Germany) 18-22 May, 1981.
    Dev Biol Stand; 1981; 50():1-398. PubMed ID: 7341286
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulatory philosophy and acceptability of cells for the production of biologicals.
    Petricciani JC
    Dev Biol Stand; 1991; 75():9-15. PubMed ID: 1794634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologicals and vaccines: regulatory perspectives.
    Petricciani JC
    Dev Biol Stand; 1986; 63():15-9. PubMed ID: 3743903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fish biologics: serodiagnostics and vaccines.
    Dev Biol Stand; 1981; 49():1-486. PubMed ID: 6118308
    [No Abstract]   [Full Text] [Related]  

  • 13. Status of WHO concerning continuous cell lines as substrates for the production of biologicals.
    Grachev V; Magrath D
    Dev Biol Stand; 1989; 70():215-9. PubMed ID: 2759349
    [No Abstract]   [Full Text] [Related]  

  • 14. Review of the current use and evaluation of cell substrates for producing biologicals in selected countries.
    Kang HN; Xu M; Rodríguez VP; Mefed K; Hanada K; Ahn KS; Gangakhedkar SJ; Pakzad SR; Prawahju EI; Lee N; Phumiamorn S; Nemec M; Meng S; Knezevic I
    Biologicals; 2015 May; 43(3):153-7. PubMed ID: 25707711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report on the International Conference on the Role of the Individual and the Community in the Research, Development, and Use of Biologicals.
    Bull World Health Organ; 1977; 55 Suppl 2(Suppl 2):167-72. PubMed ID: 305310
    [No Abstract]   [Full Text] [Related]  

  • 16. Symposium on Continuous Cell Lines as Substrates for Biologicals. Arlington, Virginia, USA (Washington, D.C.), May 26-29, 1988. Proceedings.
    Dev Biol Stand; 1989; 70():1-304. PubMed ID: 2759343
    [No Abstract]   [Full Text] [Related]  

  • 17. Viral safety of biological products in WHO policy.
    Grachev VP
    Dev Biol Stand; 1991; 75():241-6. PubMed ID: 1794628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large scale animal cell cultivation for production of cellular biologicals.
    van Wezel AL; van der Velden-de Groot CA; de Haan HH; van den Heuvel N; Schasfoort R
    Dev Biol Stand; 1985; 60():229-36. PubMed ID: 3899783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WHO Expert Committee on Biological Standardization.
    World Health Organization
    World Health Organ Tech Rep Ser; 2013; (978):1-384, back cover. PubMed ID: 24340794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Who Expert Committee on Biological Standardization.
    World Health Organization
    World Health Organ Tech Rep Ser; 2004; 926():1-109. PubMed ID: 15918537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.